Tirilazad

From Wikipedia, the free encyclopedia

Tirilazad
Systematic (IUPAC) name
(8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
Identifiers
CAS number	110101-66-1
ATC code	N07XX01
PubChem	104903
Chemical data
Formula	C38H52N6O2
Mol. mass	624.859 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Tirilazad is a drug proposed for use in the treatment of stroke, though results so far have been mixed.^[1]

[edit] References

1. ^ Tirilazad for acute ischaemic stroke. Retrieved on 2007-07-28.